Concepedia

Author

Tijl Huijbregts

Synthon (Netherlands)

Also Known As

Tijl Huijbregts

8

Publications

370

Citations

2

H-Index

14

Concepts

All Affiliations

Synthon (Netherlands)
TH

About

Tijl Huijbregts is an author at Synthon (Netherlands) specializing in drug discovery, drug development, and antibody engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

370

2

Natural Sciences

2

2

370

3

Biomolecular Engineering

1

1

214

4

Chemical Biology

1

1

156

5

Immunology

1

1

156

Tijl Huijbregts

×

2

Publications

370

Citations

2

H-Index

YearCitations

Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985

Ronald C. Elgersma, Ruud G. E. Coumans, Tijl Huijbregts,

Molecular Pharmaceutics

2015

214

Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform

Wim H.A. Dokter, Ruud Ubink, Miranda van der Lee,

Molecular Cancer Therapeutics

2014

156

Page 1